
Sign up to save your podcasts
Or
Description: Dr. Jasmin Jo interviews Dr. Michael Lim about his and his team's recent manuscript entitled: "Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated MGMT promoter", published online in Neuro-Oncology in November 2022.
4.8
1212 ratings
Description: Dr. Jasmin Jo interviews Dr. Michael Lim about his and his team's recent manuscript entitled: "Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated MGMT promoter", published online in Neuro-Oncology in November 2022.
38,713 Listeners
90,949 Listeners
293 Listeners
12,103 Listeners
2,321 Listeners
69,085 Listeners
165,736 Listeners
59,371 Listeners
317 Listeners
12,540 Listeners
28,507 Listeners
15,335 Listeners
8,874 Listeners
9,964 Listeners
7,654 Listeners